Clinical trial
The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic…
NCT00497939 · Hospital Authority, Hong Kong, Other · Unknown status
Key facts
| NCT number | NCT00497939 |
|---|---|
| Title | The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients |
| Official title | The Effectiveness of Saw Palmetto and Sanmiaoshan on International Prostate Symptom Score and Peak Urinary Flow Rate of Chinese Patients With Benign Prostatic Hyperplasia |
| Lead sponsor | Hospital Authority, Hong Kong, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia, Adrenergic Alpha-Antagonists |
| Intervention type | Drug |
| Interventions | Saw palmetto and sanmiaoshan capsule |
| Enrollment | 40 |
| Start date | Jan 1, 2006 |
| Completion | Mar 1, 2008 |
| First posted | Jul 9, 2007 |
| Last update posted | Jul 7, 2010 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: